CAB-LA (cabotegravir) long-acting injectable
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAB-LA (cabotegravir) long-acting injectable, covering 2024-02-23 to 2024-02-23. Get the full timeline:
Most recent: Clinical Trial Update: Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. [Phase 3]